Status:
COMPLETED
Total Placenta Previa Associated With the Placenta Accreta Spectrum.
Lead Sponsor:
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Conditions:
Maternal; Procedure
Eligibility:
FEMALE
17-42 years
Phase:
NA
Brief Summary
To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.
Detailed Description
Study design and patients This study analyzed the outcomes of a cohort of 372 pregnant women diagnosed with PP over five years, from November 2017 to June 2023. The patient population for the study in...
Eligibility Criteria
Inclusion
- 27th to 37th weeks of gestation
- Third trimester of pregnancy
- Pregnants had received a t-PP diagnosis via color Doppler ultrasonography (cd-USG) and/or placental MRI (p-MRI).
- All singleton pregnancies in which t-PP extended to both the anterior and posterior uterine walls, resulting in complete coverage of the internal cervical os by the placenta
Exclusion
- Any cases of low-lying/marginal placenta previa
- Preoperative hemoglobin level \< 9 g/dL
- Pregnant women with coagulation disorders
- Morbid obesity
- Multiple fetal pregnancies
- Individuals delivered before \< 27 weeks of gestation
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
277 Patients enrolled
Trial Details
Trial ID
NCT06219564
Start Date
November 1 2017
End Date
June 30 2023
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences Adana City Training and Research Hospital, Department of Obstetrics and Gynecology
Adana, Yüreğir, Turkey (Türkiye), 01230